,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['destiny 04', 'bcsm']
dr. shanu modi - starting with a summary of the most anticipated and exciting results of destiny 04 - t-dxd versus tdm1 #asco22 #cancer #bcsm 
Prof. & Chair Dept. of Heme and Oncology @ClevelandClinic @NRGonc Deputy Editor @JCOOP_ASCO Tweets are mine. No act of #Kindness is ever wasted #CleClinicCancer